The weight loss products JaDera and Xiyouji Qingzhi have been voluntarily recalled by Florida Dolphin Intertrade Corp., the company that distributes them. They are recalling the product, A.P. reports, because each could pose dangers for certain patients.
On Friday Florida Dolphin Intertrade Corp. announced that these weight loss products contain Sibutramin, a substance that works to control obesity. Sibutramin is not declared to be in these products on the label and is no longer an approved substance for weight loss.
Sibutramin not approved for weight loss
In 2010, Sibutramin was removed from the U.S. market because for some patients it had been found to dramatically increase blood pressure and pulse. Further, as A.P. reported, "patients with a history of coronary artery disease, congestive heart failure, arrhythmia or stroke" may be at greater risk if they take a product containing Sibutramin.
The substance can also interact with certain other medications in a life-threatening way, though the company claims there have been no reports of adverse side-effects from anyone taking their products. Both products were distributed by the company from between May 2011 and May 2013.
If you are taking JaDera or Xiyouji Qingzhi you are advised to stop. If you've questions about the products or about this recall, telephone 305-383-7600.